For a long time, the most advanced C. diff diagnostic tools were only found in wealthy, high-resource nations. However, 2026 is seeing a major push to bring these life-saving devices to emerging markets across Asia and Latin America. Manufacturers are developing "ruggedized" versions of molecular tests that can operate in areas with intermittent power or limited laboratory infrastructure. This...